SGRY SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES SURGERY PARTNERS, INC.
SGRY SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES SURGERY PARTNERS, INC. |
| [26-October-2026] |
SGRY shareholders will receive just $23.50 per share in an all-cash transaction valued at approximately $5.7 billion in enterprise value; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers CLICK HERE TO JOIN MILWAUKEE, Oct. 26, 2026 /PRNewswire/ -- Ademi LLP is investigating whether the proposed acquisition of Surgery Partners (NYSE: SGRY) by HealthSpan, provides fair value to Surgery Partners' public shareholders and whether Surgery Partners' Board adequately protected shareholder interests in negotiating and approving the transaction.
Are You a SGRY Shareholder? You may also contact Guri Ademi at gademi@ademilaw.com or toll-free at 866-264-3995. What Is Ademi LLP Investigating? Substantial change-of-control benefits available to Surgery Partners insiders in connection with the transaction; Restrictions on competing transactions, including a significant termination penalty that may discourage another potential buyer from making a superior proposal; and The conduct of Surgery Partners' Board of Directors in negotiating and approving the transaction and whether the Board fulfilled its duties to public shareholders. What Should SGRY Shareholders Do? Guri AdemiAdemi LLP About Ademi LLP Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE Ademi LLP | ||
Company Codes: NYSE:SGRY |













